Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
23.3%
% of FBT's 31 holdings also in IDNA
15.6%
% of IDNA's 49 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 4.5% | 6.7% | 4.5% |
|
GILEAD SCIENCES INC | 3.6% | 5.9% | 3.6% |
|
INCYTE CORP | 3.5% | 4.9% | 3.5% |
 |
BIONTECH SE SPONSORED ADR | 3.4% | 5.0% | 3.4% |
|
SAREPTA THERAPEUTICS INC | 3.3% | 4.2% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IDNA
|
NATERA INC | 4.3% |
|
CORCEPT THERAPEUTICS INC | 4.1% |
|
ACADIA PHARMACEUTICALS INC | 3.9% |
 |
ARGENX SE ADR | 3.8% |
|
REPLIGEN CORP | 3.8% |
|
NEUROCRINE BIOSCIENCES INC | 3.7% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
WATERS CORP | 3.6% |
 |
ALKERMES PLC | 3.6% |
FBT Underweight Relative to IDNA
 |
BEIGENE, LTD. | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
 |
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
|
ARCELLX, INC. | -3.9% |
 |
GSK PLC | -3.4% |
|
MERCK & CO. INC. | -3.3% |
|
TWIST BIOSCIENCE CORP. | -3.1% |
 |
GENMAB A/S | -3.0% |